Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sukyung Ahn"'
Publikováno v:
Journal of materials chemistry. B. 8(9)
Ferrocene-containing nanoparticles show reversible redox activity that could trigger drug release mediated by reactive oxygen species (ROS). In this study, four ferrocene-containing polymers, comprising ferrocenylmethyl methacrylate (FMMA)-methacryli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334e65814fc91a78e2fc290cbb220d67
https://pubmed.ncbi.nlm.nih.gov/32043093
https://pubmed.ncbi.nlm.nih.gov/32043093
Autor:
Eun-Hye Lee, Soo Jung Ryu, Dahye Lee, Jin Hee Ahn, Myung Ae Bae, Geum Ran Kim, Don Hang Lee, Minhee Kim, Suvarna H. Pagire, Jin Sook Song, Kyu-Seok Hwang, Sukyung Ahn, Jin Hee Maeng, Haushabhau S. Pagire, Eun Jung Bae
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:529-532
A series of glutamic acid derivatives was synthesized and evaluated for their antioxidant activity and stability. We found several potent and stable glutamic acid derivatives. Among them, compound 12b exhibited good in vitro activity, chemical stabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df350a91c55de39b724462151aeb47b6
https://doi.org/10.1016/j.bmcl.2017.11.012
https://doi.org/10.1016/j.bmcl.2017.11.012
Autor:
Phei Er Saw, Eunbeol Lee, Jinho Park, Jinjoo Kim, Minsuk Choi, Jinju Lee, Omid C. Farokhzad, Hyungjun Kim, Sukyung Ahn, Sangyong Jon
Publikováno v:
THERANOSTICS(5): 7
Theranostics
Theranostics
Standardized poly(ethylene glycol)-modified (PEGylated) liposomes, which have been widely used in research as well as in pre-clinical and clinical studies, are typically constructed using PEG with a molecular weight of 2000 Da (PEG(2000)). Targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140767a037dbeb72433a72c06793661a
https://doi.org/10.7150/thno.10732
https://doi.org/10.7150/thno.10732
Autor:
Sunghyun Kim, Sangyong Jon, Minsuk Choi, Yu-Mi Lee, Phei Er Saw, In-Hyun Lee, Hyungjun Kim, Sukyung Ahn, Hyungsu Jeon, Daejin Kim
Publikováno v:
Cancer Research. 74:2144-2151
STAT3 promotes the survival, proliferation, metastasis, immune escape, and drug resistance of cancer cells, making its targeting an appealing prospect. However, although multiple inhibitors of STAT3 and its regulatory or effector pathway elements hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173f702737a32257db6b624b2dc85aac
https://doi.org/10.1158/0008-5472.can-13-2187
https://doi.org/10.1158/0008-5472.can-13-2187
Autor:
Eui-Cheol Shin, Sukmo Kang, Daejin Kim, Minsuk Choi, In-Hyun Lee, Sangyong Jon, Phei Er Saw, Sukyung Ahn
Publikováno v:
Advanced Healthcare Materials. 3:1194-1199
Golden vaccine for cancers. Gold nanoparticles enable efficient antigen delivery to dendritic cells and then activate the cells to facilitate cross-presentation, inducing antigen-specific cytotoxic T-lymphocyte responses for effective cancer therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de84e48fbf286b104f2ba99bfc51d44
https://doi.org/10.1002/adhm.201300597
https://doi.org/10.1002/adhm.201300597
Publikováno v:
Journal of Controlled Release. 170:226-232
Despite the therapeutic potential of exendin-4 as a glucagon-like peptide-1 (GLP-1) mimetic for the treatment of type 2 diabetes, its utility has so far been limited because of the low level of patient compliance due to the requirement for frequent i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aec42a1fae850b1f46b65f068838134
https://doi.org/10.1016/j.jconrel.2013.05.031
https://doi.org/10.1016/j.jconrel.2013.05.031
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 256
Although the peptide, exenatide, has been widely used as a drug for the treatment of type 2 diabetes, its short plasma half-life requires frequent subcutaneous injection, resulting in poor patient compliance in addition to side effects such as infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2cc22f32dec472ac9e9403d1eb36d67
https://pubmed.ncbi.nlm.nih.gov/28457895
https://pubmed.ncbi.nlm.nih.gov/28457895
Autor:
Daejin Kim1, In-Hyun Lee1, Sunghyun Kim1, Minsuk Choi1, Hyungjun Kim1, Sukyung Ahn1, Phei Er Saw1, Hyungsu Jeon1, Yumi Lee1, Sangyong Jon1 syjon@kaist.ac.kr
Publikováno v:
Cancer Research. 4/15/2014, Vol. 74 Issue 8, p2144-2151. 8p.